|
|
Volumn 19, Issue 6, 2013, Pages 660-663
|
|
Cancer's true breakthroughs
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BORTEZOMIB;
CYCLOPHOSPHAMIDE;
IBRUTINIB;
IMATINIB;
IPILIMUMAB;
LETROZOLE;
PALBOCICLIB;
PEMBROLIZUMAB;
RITUXIMAB;
VEMURAFENIB;
CRIZOTINIB;
DARATUMUMAB;
MONOCLONAL ANTIBODY;
PYRAZOLE DERIVATIVE;
PYRIDINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
ADVANCED CANCER;
BREAST CANCER;
CANCER IMMUNOTHERAPY;
CANCER RESEARCH;
CHRONIC MYELOID LEUKEMIA;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MALIGNANT NEOPLASM;
MELANOMA;
NOTE;
PRIORITY JOURNAL;
SOLID MALIGNANT NEOPLASM;
CLINICAL TRIAL (TOPIC);
DRUG CONTROL;
DRUG DEVELOPMENT;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DRUG AND NARCOTIC CONTROL;
DRUG DISCOVERY;
HUMANS;
PYRAZOLES;
PYRIDINES;
PYRIMIDINES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84880976792
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm.3245 Document Type: Note |
|
Times cited : (12)
|
|
References (0)
|
